loader
Please Wait
Applying Filters...

Approved Drug Products containing GW282974X listed in the FDA Orange Book. Original Data : FDA Website

Menu
$ API Ref.Price (USD/KG) : 2,937Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1NATCO PHARMA LTD

02 1NOVARTIS

03 1TEVA PHARMS USA INC

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

LAPATINIB DITOSYLATE

Brand Name : LAPATINIB DITOSYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 250MG BASE

Approval Date : 2020-09-29

Application Number : 203007

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

02

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

LAPATINIB DITOSYLATE

Brand Name : TYKERB

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 250MG BASE

Approval Date : 2007-03-13

Application Number : 22059

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

03

Discovery on Target
Not Confirmed
arrow
arrow
Discovery on Target
Not Confirmed

LAPATINIB DITOSYLATE

Brand Name : LAPATINIB DITOSYLATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 250MG BASE

Approval Date : 2024-08-16

Application Number : 217968

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank